Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
Source: Finance News Network
15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
Read More04 Mar 2024 - Sean Gregory - Managing Director - Sarytogan Graphite (ASX:SGA) through its 100% owned subsiduary company, Ushtogan LLP, is the 100% owner of the Sarytogan Graphite Project. The Sarytogan Graphite Project is located in the Karaganda region of Central Kazakhstan and the exploration concession covers 70 km2. As its name suggests, the Sarytogan Graphite Project is prospective for graphite and a meaningful initial JORC compliance resource has already been delineated on the project.
Read More26 Nov 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Read More25 Oct 2024 - In the keynote address for the inaugural Semiconductor Australia conference, Digital Playground Co-Founder and General Partner Peter Barrett discusses Australia's potential to lead in next-generation technology.
Read More10 Oct 2023 - Dr Mike Jones - Managing Director - Impact Minerals (ASX:IPT) is an exploration company listed on the ASX in November 2006. The Company manages extensive tenement holdings (>4,000 km2) within Australia featuring significant potential for high-grade mineral deposits of gold, silver, lead, zinc, copper, nickel and PGM’s.
Read More05 Oct 2022 - QX Resources Limited (ASX:QXR) Managing Director Stephen Promnitz discusses what brought him to QXR, and the company's assets and development stage.
Read More10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth
Read More19 Mar 2024 - Torque Metals Limited (ASX:TOR) Managing Director Cristian Moreno discusses the roadmap for the company and promising recent results.
Read More26 Mar 2024 - Mayfield Group (ASX:MYG) CEO Andrew Rowe provides an overview of the company, discussing its divisions, growth strategy, pipeline of work, dividend policy and outlook.
Read More16 May 2023 - ABx Group Limited (ASX:ABX) CEO and Managing Director Dr Mark Cooksey discusses the advantages of ionic clay rare earths deposits, the company's exploration program, its plays for a scoping study and a pilot plant, and its new process to develop fluorine from aluminium smelting waste.
Read More
